Induction of Transcriptional Inhibitor HES1 and the Related Repression of Tumor-Suppressor TXNIP Are Important Components of Cell-Transformation Program Imposed by Oncogenic Kinase NPM-ALK.


Journal

The American journal of pathology
ISSN: 1525-2191
Titre abrégé: Am J Pathol
Pays: United States
ID NLM: 0370502

Informations de publication

Date de publication:
08 2022
Historique:
received: 12 10 2021
revised: 01 04 2022
accepted: 09 05 2022
pubmed: 1 6 2022
medline: 17 8 2022
entrez: 31 5 2022
Statut: ppublish

Résumé

This study reports that hairy and enhancer of split homolog-1 (HES1), known to repress gene transcription in progenitor cells of several cell lineages, was strongly expressed in cells and tissues of T-cell lymphoma expressing the oncogenic chimeric tyrosine kinase nucleophosmin (NPM)-anaplastic lymphoma kinase [ALK; ALK

Identifiants

pubmed: 35640677
pii: S0002-9440(22)00148-1
doi: 10.1016/j.ajpath.2022.05.005
pmc: PMC9379685
pii:
doi:

Substances chimiques

Carrier Proteins 0
TXNIP protein, human 0
Transcription Factor HES-1 0
HES1 protein, human 149348-15-2
Anaplastic Lymphoma Kinase EC 2.7.10.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1186-1198

Subventions

Organisme : NCI NIH HHS
ID : R01 CA228457
Pays : United States

Informations de copyright

Copyright © 2022 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Références

Oncogene. 1994 Jun;9(6):1567-74
pubmed: 8183550
J Invest Dermatol. 2018 May;138(5):1126-1136
pubmed: 29248547
Mol Endocrinol. 2014 Aug;28(8):1211-20
pubmed: 24911120
Blood. 2003 Mar 1;101(5):1919-27
pubmed: 12424201
Sci Rep. 2014 Feb 04;4:3963
pubmed: 24492635
Immunity. 2010 Nov 24;33(5):671-84
pubmed: 21093323
Oncogene. 1997 May 8;14(18):2175-88
pubmed: 9174053
Nat Immunol. 2013 Dec;14(12):1277-84
pubmed: 24185616
Blood. 1997 Oct 15;90(8):2901-10
pubmed: 9376569
Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4181-6
pubmed: 8633037
J Biol Chem. 2006 Aug 4;281(31):21884-21891
pubmed: 16766796
J Immunol. 2013 Dec 15;191(12):6200-7
pubmed: 24218456
Development. 2007 Apr;134(7):1243-51
pubmed: 17329370
Cancer Res. 2017 Jul 1;77(13):3442-3454
pubmed: 28536281
Science. 1994 Mar 4;263(5151):1281-4
pubmed: 8122112
PLoS One. 2013 May 08;8(5):e63757
pubmed: 23667670
Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20852-7
pubmed: 19088198
Br J Haematol. 2015 Mar;168(6):771-83
pubmed: 25559471
Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):9964-9
pubmed: 16766651
Nat Cell Biol. 2004 Jun;6(6):547-54
pubmed: 15156153
Front Immunol. 2014 Jan 09;4:514
pubmed: 24409188
Genes Dev. 2019 May 1;33(9-10):511-523
pubmed: 30862661
FASEB J. 2006 Jan;20(1):121-3
pubmed: 16254043
Cancer Lett. 2014 Jul 10;349(1):1-7
pubmed: 24727284
Leukemia. 2011 Mar;25(3):440-8
pubmed: 21151022
Cancer Biol Ther. 2015;16(3):353-9
pubmed: 25781910
Biochim Biophys Acta. 2010 Dec;1804(12):2153-61
pubmed: 20816878
Genes (Basel). 2011 Feb 22;2(1):219-28
pubmed: 24710146
Semin Oncol. 2009 Apr;36(2 Suppl 1):S27-35
pubmed: 19393833
EMBO J. 1999 Apr 15;18(8):2196-207
pubmed: 10205173
J Immunol. 2002 Jan 1;168(1):466-74
pubmed: 11751994
J Immunol. 2000 Jun 15;164(12):6287-95
pubmed: 10843682
Stem Cells. 2006 Apr;24(4):876-88
pubmed: 16513761
Oncogene. 2011 Mar 17;30(11):1372-8
pubmed: 21102525
Blood. 2006 Aug 1;108(3):1058-64
pubmed: 16861352
Nat Med. 2005 Jun;11(6):623-9
pubmed: 15895073
Am J Pathol. 2013 Dec;183(6):1971-80
pubmed: 24404580
J Exp Med. 2013 Jan 14;210(1):71-84
pubmed: 23267012
J Biol Chem. 2010 Feb 5;285(6):3997-4005
pubmed: 19959470
Oncol Lett. 2017 Aug;14(2):2053-2058
pubmed: 28781647
Curr Opin Oncol. 2015 Mar;27(2):118-24
pubmed: 25588040
Cancer Res. 2014 Nov 1;74(21):6094-106
pubmed: 25193384
Nat Med. 2007 Nov;13(11):1341-8
pubmed: 17922009
Mol Cell Biol. 1997 Apr;17(4):2312-25
pubmed: 9121481
Biochem Biophys Res Commun. 2015 Oct 2;465(4):838-44
pubmed: 26315267
Curr Top Dev Biol. 2014;110:263-83
pubmed: 25248479
Blood. 2017 Feb 16;129(7):823-831
pubmed: 27879258
Blood. 2011 Sep 15;118(11):3062-71
pubmed: 21765024
Proteins. 2014 Apr;82(4):537-45
pubmed: 24403087
Antioxid Redox Signal. 2012 Dec 15;17(12):1738-47
pubmed: 22530689

Auteurs

Qian Zhang (Q)

Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Hong Y Wang (HY)

Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Anindita Nayak (A)

Department of Biological Sciences, National University of Singapore, Singapore.

Selene Nunez-Cruz (S)

Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Artur Slupianek (A)

Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Xiaobin Liu (X)

Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Johnvesly Basappa (J)

Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Jing-Song Fan (JS)

Department of Biological Sciences, National University of Singapore, Singapore.

Seble Chekol (S)

Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Reza Nejati (R)

Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Agata M Bogusz (AM)

Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Suzanne D Turner (SD)

Department of Pathology, University of Cambridge, Cambridge, United Kingdom.

Kunchithapadam Swaminathan (K)

Department of Biological Sciences, National University of Singapore, Singapore.

Mariusz A Wasik (MA)

Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: mariusz.wasik@fccc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH